Squarepoint’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-38,193
| Closed | -$125K | – | 2454 |
|
|
2024
Q1 | $125K | Sell |
38,193
-34,771
| -48% | -$114K | ﹤0.01% | 2209 |
|
|
2023
Q4 | $256K | Buy |
+72,964
| New | +$256K | ﹤0.01% | 2022 |
|
|
2023
Q2 | – | Sell |
-67,048
| Closed | -$666K | – | 2365 |
|
|
2023
Q1 | $666K | Buy |
+67,048
| New | +$666K | ﹤0.01% | 1345 |
|
|
2022
Q3 | – | Sell |
-10,964
| Closed | -$44K | – | 2042 |
|
|
2022
Q2 | $44K | Sell |
10,964
-17,328
| -61% | -$69.5K | ﹤0.01% | 1969 |
|
|
2022
Q1 | $126K | Sell |
28,292
-73,187
| -72% | -$326K | ﹤0.01% | 2000 |
|
|
2021
Q4 | $406K | Buy |
101,479
+56,352
| +125% | +$225K | ﹤0.01% | 1718 |
|
|
2021
Q3 | $396K | Buy |
45,127
+26,858
| +147% | +$236K | ﹤0.01% | 1487 |
|
|
2021
Q2 | $207K | Buy |
+18,269
| New | +$207K | ﹤0.01% | 2205 |
|
|
2020
Q4 | – | Sell |
-39,349
| Closed | -$292K | – | 2488 |
|
|
2020
Q3 | $292K | Sell |
39,349
-106,341
| -73% | -$789K | ﹤0.01% | 1688 |
|
|
2020
Q2 | $608K | Buy |
145,690
+115,182
| +378% | +$481K | 0.01% | 1186 |
|
|
2020
Q1 | $75K | Buy |
+30,508
| New | +$75K | ﹤0.01% | 1676 |
|
|
2019
Q4 | – | Sell |
-61,695
| Closed | -$325K | – | 2356 |
|
|
2019
Q3 | $325K | Sell |
61,695
-62,343
| -50% | -$328K | ﹤0.01% | 1773 |
|
|
2019
Q2 | $744K | Buy |
124,038
+48,734
| +65% | +$292K | 0.01% | 1416 |
|
|
2019
Q1 | $680K | Buy |
75,304
+7,099
| +10% | +$64.1K | 0.01% | 1311 |
|
|
2018
Q4 | $566K | Buy |
68,205
+56,505
| +483% | +$469K | 0.01% | 1168 |
|
|
2018
Q3 | $161K | Buy |
+11,700
| New | +$161K | ﹤0.01% | 1814 |
|
|
2017
Q4 | – | Sell |
-22,070
| Closed | -$159K | – | 2049 |
|
|
2017
Q3 | $159K | Buy |
+22,070
| New | +$159K | ﹤0.01% | 1427 |
|